STAT-Diagnostica Raises $22.1 Mln
STAT-Diagnostica closed a Series B round of financing totaling $22.1 million/17 million Euros led by new investor Kurma Life Sciences Partners. Other new investors participating in the round include: Idinvest; Boehringer Ingelheim Venture Fund; and, Caixa Capital Risc, the venture capital division of “la Caixa;” as well as existing investors Ysios Capital and Axis. Barcelona-based STAT-Dianostica develops "near patient testing systems" that aim to simplify and reduce time to results for the diagnosis of certain medical conditions.
6 May 2013•5 mins read
